Multitarget inhibition of CDK2, EGFR, and tubulin by phenylindole derivatives: Insights from 3D-QSAR, molecular docking, and dynamics for cancer therapy
Fig 8
RMSD Analysis of Active Molecules Pred9 and Pred10 in Complex with A: Tubulin, B: CDK2, and C: EGFR.